Schering Plough Wire

Results 1 - 20 of 707 in Schering Plough

1. Merck earnings preview: No miracles expected

   15 hrs ago | Blogging Stocks

   Merck & Co. is set to report earnings Monday, July 21, ahead of the opening bell.

   Comment?

   Related Topix: Biotech, Merck , Medicine, Healthcare Industry

2. Earnings Preview: Schering-Plough Corp.

   21 hrs ago | Seeking Alpha

   Guidance Analysts are looking for a profit of 41c on revenue of $4.77B. The consensus range is 28c to 48c for EPS, and revenue of $4.55B to $4.92B, according to First Call Analyst Views Positive drivers for ...

   Comment?

   Related Topix: Biotech, Medicine, Healthcare Industry, Merck

3. Ultra Saber Pour-On

   Yesterday | The Prairie Star

   Schering-Plough Animal Health Corp. announces the release of Ultra Saber, a new pour-on insecticide that controls horn flies on beef cattle and calves.

   Comment?

   Related Topix: Biotech, Medicine, Healthcare Industry

4. Ph.D. Scientist - Immunoassays

   Thursday | Nature Biotechnology

   "Come build the company of the future" Fred Hassan, CEO Schering-Plough Our plans for tomorrow are as bold as yours.

   Comment?

   Related Topix: Biotech, Medicine, Healthcare Industry, Biology, Science

5. Schering-Plough Corporation's Pegintron Cuts Melanoma Return Risk in Phase 3 Study

   Friday Jul 11 | BioSpace

   Today, Schering-Plough and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival , ...

   Comment?

   Related Topix: University of Nebraska System, Oncology, Medicine, Medical Center (University of Nebraska System), Skin Cancer, Health, Research College of Nursing, Biotech, Healthcare Industry, The College of Wooster

6. Cramer's Take on Top-Searched Stocks

   Apr 26, 2008 | TheStreet.com

   CLICK HERE NOW The phrase "a new low" is getting a lot of use lately in the current market.

   Comment?

   Related Topix: TheStreetcom, Media, Computers, Business News

7. MidnightTrader Analyst Play: Schering-Plough

   Tuesday Jul 15 | TradingMarkets.com

   Schering-Plough closed up 4.4% at 22.32, ahead of the gain to 21.60 in the pre-market session after Lehman Brothers raised the issue to Overweight from Equal Weight.

   Comment?

   Related Topix: Biotech, Medicine, Healthcare Industry

8. Before the Bell: General Motors, Johnson & Johnson, Wachovia in focus

   Tuesday Jul 15 | MarketWatch

   Stock market futures pointed sharply lower Tuesday after the dollar hit a new low against the euro and General Motors said it needs to raise around $15 billion of liquidity, with testimony from Federal Reserve ...

   Comment?

   Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry

9. Business News: Drug firms to cut jobs in New Jersey

   Monday Jul 14 | CourierPostOnline

   More than 800 pharmaceutical jobs will be leaving New Jersey starting in August.

   Comment?

   Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Kenilworth, NJ, New Brunswick, NJ

10. Is Elan in Double Trouble?

    Sunday Jul 13 | Seeking Alpha

    A few weeks ago I blogged about a couple of analysts cautioning investors that shares of Irish drugmaker Elan would be volatile surrounding the Alzheimer's conference the end of this month.

    Comment?

    Related Topix: Biotech, Elan Corporation Plc

11. Long Term Pegylated Interferon Alfa-2b Therapy In Stage III Melanoma...

    Saturday Jul 12 | MediLexicon

    Schering-Plough and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival , according to ...

    Comment?

    Related Topix: Oncology, Medicine, Skin Cancer, Biotech, Healthcare Industry

12. Long Term Pegylated Interferon Alfa-2b Therapy In Stage III...

    Saturday Jul 12 | Medical News Today

    Main Category: Dermatology Also Included In: Cancer / Oncology ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 12 Jul 2008 - 0:00 PDT Schering-Plough and the EORTC announced ...

    Comment?

    Related Topix: Skin Cancer, Medicine, Oncology, Biotech, Healthcare Industry

13. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma...

    Friday Jul 11 | Fox News

    Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival Comtex KENILWORTH, N.J., July 11, 2008 /PRNewswire-FirstCall via ...

    Comment?

    Related Topix: Kenilworth, NJ, University of Nebraska System, Oncology, Medicine, Medical Center (University of Nebraska System), Skin Cancer, Health, Research College of Nursing, Biotech, Healthcare Industry

14. Health Winners & Losers: Momenta

    Apr 26, 2008 | TheStreet.com

    Health stocks skidded into the weekend on relatively light news Friday -- just around the corner from the start of second-quarter earnings .

    Comment?

    Related Topix: Financial Markets, Biotech, SanofiSynthlabo, Medicine, Forest Labs, Healthcare Industry, Patent / Trademark Law, Law

15. Schering-Plough drug improves cancer relapse rate

    Friday Jul 11 | MSN Money

    Schering-Plough Corp. said Friday its drug Pegintron showed mixed results in a study on late-stage cancer patients, as it improved the amount of time a patient survives without relapsing, but not the overall ...

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Skin Cancer

16. Deafening Silence From Merck

    Thursday Jul 10 | Investopedia

    Drug maker Merck has seen its stock price drop nearly 37% since the beginning of the year, and a recent downgrade by UBS analyst Roopesh Patel, could put even more pressure on the shares. 2 comments

    Related Topix: Medicine, Biotech, Merck , Healthcare Industry

17. Margaret Weinstein, 87, East Brunswick

    Thursday Jul 10 | Courier News Online

    Margaret 'Meg' Seitner Weinstein, a resident of East Brunswick from the early 1960s until 1980, died July 4, 2008.

    Comment?

    Related Topix: East Brunswick, NJ, Biotech, Medicine, Healthcare Industry, Madison, NJ

18. A Drug to Fertilize Schering-Plough's Growth?

    Wednesday Jul 9 | Fool.com

    Yesterday, the company announced results of a trial for a drug that could help Schering take a few steps on the road to recovery.

    Comment?

    Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Cholesterol, Health, Healthcare Law, Law

19. Former NFL star: Don't pass on Schering-Plough

    Wednesday Jul 9 | The Jersey Journal

    Like Big Blue, Schering-Plough's strengths are being undervalued, he said. "For us, this could be a great chance to go long," Brown wrote of the stock.

    Comment?

    Related Topix: Sports, NFL Football, New York Giants

20. Cramer: Feds Step Up to the Plate

    Apr 26, 2008 | TheStreet.com

    This post appeared earlier today on RealMoney . Click here for a free trial, and enjoy incisive commentary all day, every day.

    Comment?

    Related Topix: Financial Services, Fannie Mae, Banking, Bank of America, Financial Markets